University at Buffalo at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

University at Buffalo brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on quantitative pharmacology, from modeling antibody-based constructs in preclinical and clinical work to its future in clinical drug development. Its sessions also present a form of factor VIII designed to build lasting immune tolerance.

OrganizationAAPS 2026 PharmSci 360 Attendance
Talk
Mon Oct 26
1:30pm–2:30pm
Keynote: The Present and Future of Quantitative Pharmacology in Clinical Drug Development - Pushing Scientific Boundaries for Patient Impact
207
Preclinical, Clinical, and Translational Sciences · with Genentech
Talk
Mon Oct 26
3:00pm–3:15pm
Part of Rapid Fire: Novel Modalities, Targeted Delivery and Disease Focused Translational Applications
Tolerogenic Form of FVIII Provides a Safe, Durable Tolerance
207
Preclinical, Clinical, and Translational Sciences
Talk
Tue Oct 27
10:30am–11:00am
Part of Symposium: Innovating Cancer Therapy: Translational Approaches Across New Modalities
Strategic Preclinical and Clinical PK/PD Modeling of Novel Antibody-Based Constructs
206
Preclinical, Clinical, and Translational Sciences

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University at Buffalo

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction